Peter M. Hecht - 03 Jan 2022 Form 4 Insider Report for Cyclerion Therapeutics, Inc. (CYCN)

Role
Chief Executive Officer, Director
Signature
/s/ Gary J. Simon, Attorney-in-Fact
Issuer symbol
CYCN
Transactions as of
03 Jan 2022
Net transactions value
$0
Form type
4
Filing time
24 Jan 2022, 10:38:25 UTC
Previous filing
07 Jun 2021
Next filing
22 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYCN Employee Stock Option (Right to Buy) Award $0 +52,950 $0.000000 52,950 03 Jan 2022 Common Stock 52,950 $1.78 Direct F1
transaction CYCN Employee Stock Option (Right to Buy) Award $0 +430,000 $0.000000 430,000 20 Jan 2022 Common Stock 430,000 $1.21 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable as to 8.33333% of the shares of Common Stock on each monthly anniversary of January 3, 2022.
F2 The stock option vests and becomes exercisable as to 2.08333% of the shares of Common Stock on each monthly anniversary of January 20, 2022.